Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

5th Apr 2013 10:22

RNS Number : 6793B
Immunodiagnostic Systems Hldgs PLC
05 April 2013
 



5 April 2013

 

Immunodiagnostic Systems Holdings Plc ("IDS" or "the Company" or the "Group")

 

Directors' share purchases and issue of share options

 

Immunodiagnostic Systems Holdings plc (AIM: IDH), a leading producer of diagnostic testing kits and automated systems for the clinical and research markets, announces that it was informed on 4 April 2013 the following Director's shares were purchased:

 

Number of shares acquired

Share price

Resultant holding

Resultant %(1)

Patrik Dahlen

20,000

288p

39,032

0.14%

Chris Yates

5,000

287p

5,000

0.02%

(1) Based on 28,336,915 ordinary shares in issue

 

In addition, IDS announce the issue of share options as part of an on-going programme of incentives for its employees. Following the recommendation of the Remuneration Committee, IDS has today agreed to grant 48,746 share options to Chris Yates under the Company's Unapproved Share Option Scheme at an exercisable price of 279p per share. The exercise of options granted is subject to the achievement of certain performance conditions set by the Board and the options are exercisable over a period of three to ten years. In addition to the above options grant, options were granted to other Approved Grantees in respect of a further 15,372 shares.

 

For further information:

Immunodiagnostic Systems Holdings PLC

Tel : +44 (0)191 519 0660

Patrik Dahlen, Chief Executive Officer

Chris Yates, Finance Director

 

Peel Hunt LLP

Tel : +44 (0)207 418 8900

James Steel

Dr Vijay Barathan

 

FTI Consulting

 

Tel : +44 (0)207 831 3113

Ben Atwell

Simon Conway

Mo Noonan

 

About Immunodiagnostic Systems Holdings PLC

The Group operates in the in-vitro diagnostics ("IVD") market by designing, manufacturing and selling immunoassay kits as well as its automated analyser, the IDS-iSYS System. The IDS product range is used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies.

http://www.idsplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGCGDSIBGBGXU

Related Shares:

IDH.L
FTSE 100 Latest
Value8,809.74
Change53.53